Fund details
A 46-year-old venture capital firm managing over $5 billion in assets, focused on investing in companies driving innovation.
Go to profile
Partners related to this fund
Johnny Hu
Principal
At Menlo Ventures, Johnny focuses on biotechnology and life sciences, with an emphasis on novel therapeutics. Hands-on experience includes developing gene-editing technologies licensed to companies like Editas Medicine and Beam Therapeutics. Prior to Menlo, Johnny contributed to several early-stage biotech investments at Longitude Capital and worked with Omega Funds to advance medical technologies.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Investment ranges
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Biotech
Consumer
Cybersecurity
Fintech
Health
Logistics
Enterprise
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
